ORYZA PHARMACEUTICALS INC.

97009108 | Trademark

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed Sept. 2, 2021
Serial No. 97009108
Examining Attorney MELISSA STURMAN
Class Pharmaceutical preparations for curing and alleviating various illnesses, namely, hypertension, angina pectoris, heart failure, various conditions accompanied by spasm of smooth muscle, namely, vascular spasm associated with acute myocardial infarction, angina pectoris, peripheral and pulmonary embolism, peripheral vascular disease with a vasospastic element and certain cerebral angiospastic states and visceral spasm, particularly ureteral, biliary or gastrointestinal, and attention deficit hyperactivity disorder; Nutraceuticals for use as a dietary supplement for the treatment of various dietary supplemental needs; Nutraceuticals for use as a dietary supplement; 005; 006; 018; 044; 046; 051; 052; 100; 101
ORYZA PHARMACEUTICALS INC.
Case Type Trademark Service mark
Status An appeal of a final refusal to register the mark is pending before the Trademark Trial and Appeal Board. For further information, see TTABVUE on the Trademark Trial and Appeal Board web page.
Opposition 97009108
In re Oryza Pharmaceuticals, Inc.
  • Oryza Pharmaceuticals, Inc.;
Last Updated: 1 week, 4 days ago
Filing Date # Docket Text
2/28/2025REPLY BRIEF FILED - CHECK TTAB FILES
2/7/2025
2/7/2025EXAMINERS STATEMENT - COMPLETED
2/7/2025EXAMINERS STATEMENT E-MAILED
2/7/2025NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
12/12/2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
6/11/2024
6/11/2024ACTION CONTINUING FINAL - COMPLETED
6/11/2024ACTION DENYING REQ FOR RECON E-MAILED
6/11/2024NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
2/8/2024
2/8/2024EXPARTE APPEAL RECEIVED AT TTAB
2/8/2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
2/8/2024EX PARTE APPEAL-INSTITUTED
2/8/2024TTAB Proceeding Filed: In re Oryza Pharmaceuticals, Inc., 97009108
11/9/2023
11/9/2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
11/9/2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
8/10/2023
8/10/2023FINAL REFUSAL WRITTEN
8/10/2023FINAL REFUSAL E-MAILED
8/10/2023NOTIFICATION OF FINAL REFUSAL EMAILED
7/22/2023
7/21/2023TEAS/EMAIL CORRESPONDENCE ENTERED
7/20/2023
7/20/2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
7/20/2023CORRESPONDENCE RECEIVED IN LAW OFFICE
4/14/2023
4/14/2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
4/14/2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
1/22/2023
1/22/2023NON-FINAL ACTION WRITTEN
1/22/2023NON-FINAL ACTION E-MAILED
1/22/2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/1/2022
11/30/2022TEAS/EMAIL CORRESPONDENCE ENTERED
11/29/2022
11/29/2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/29/2022CORRESPONDENCE RECEIVED IN LAW OFFICE
6/3/2022
6/3/2022NON-FINAL ACTION WRITTEN
6/3/2022NON-FINAL ACTION E-MAILED
6/3/2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
6/2/2022
5/31/2022ASSIGNED TO EXAMINER
10/15/2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
9/6/2021NEW APPLICATION ENTERED
9/2/2021
9/2/2021
9/2/2021